Farallon Capital Management LLC Cyclerion Therapeutics, Inc. Transaction History

Farallon Capital Management LLC

  • $19.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020
SELL
$1.8 - $13.43 $47,930 - $357,614
-26,628 Reduced 7.07%
350,000 $952,000
Q3 2019

Nov 14, 2019
SELL
$8.12 - $14.54 $1.36 Million - $2.43 Million
-167,457 Reduced 30.78%
376,628 $4.57 Million
Q2 2019

Aug 14, 2019
SELL
$9.6 - $22.85 $2.88 Million - $6.86 Million
-300,000 Reduced 35.54%
544,085 $6.23 Million
Q1 2019

May 15, 2019
BUY
$12.5 - $21.03 $10.6 Million - $17.8 Million
844,085 New
844,085 $12.5 Million

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0
View Full List

About Cyclerion Therapeutics, Inc.

CYCN Quotes by TradingView
  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $139M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email